In the U.S. 32 million people suffer from food allergies. Many are life threatening and testing is crucial.
Kenota is decentralizing allergy testing with a proprietary approach that employs rapid, point of care instrumentation. Capable of swiftly quantifying a patient’s sensitization to allergens, our system is compact, streamlined and can be administered easily by allergists and their staff.
Designed with allergists in mind
Uncovers sensitizations with a few drops of blood
Easy to administer: results and reports generated on the spot
Allergists can provide end-to-end care in a single visit – no need for lab referrals
Developed concept for in-clinic allergy testing system
Established scalable 33,000 square-foot manufacturing facility in Waterloo Region, Canada
Raised $11 million in Series A funding
Clinical studies completed
510(k) clearance and CLIA waiver approval
Kenota Health is an entrepreneurially minded team with deep scientific, clinical and commercial expertise. An idea first sparked in the tech hotbed of Waterloo Region has grown into a team of passionate and innovative professionals, collectively focused on elevating healthcare through the world’s best data and testing technology.
